'Incredibly Exciting': Diabetes Drug With CV Benefits

The FDA ' s recent addition of a cardiovascular indication for diabetes drug empagliflozin is a significant milestone in diabetes care, says Dr Anne Peters.
Source: Medscape Diabetes & Endocrinology Podcast - Category: Endocrinology Authors: Source Type: podcasts